Showing results (221-230 of 282) with videos related to
Sort By:
Pageof 29
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 12, 2005
Hepatic stellate cells and fibrosis progression in patients with nonalcoholic fatty liver diseaseAriel E Feldstein, Bettina G Papouchado, Paul Angulo, et al.Developmental Immunology|May 13, 2003
Oral tolerance and pyruvate dehydrogenase in patients with primary biliary cirrhosisAyako Suzuki, Judy Van de Water, M Eric Gershwin, et al.Journal of Clinical Gastroenterology|July 19, 2016
Combination Therapy of All-Trans Retinoic Acid With Ursodeoxycholic Acid in Patients With Primary Sclerosing Cholangitis: A Human Pilot StudyDavid N Assis, Osama Abdelghany, Shi-Ying Cai, et al.Anticancer Research|December 29, 2010
PI-103 and sorafenib inhibit hepatocellular carcinoma cell proliferation by blocking Ras/Raf/MAPK and PI3K/AKT/mTOR pathwaysRoberto Gedaly, Paul Angulo, Jonathan Hundley, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 19, 2010
A short version of a HRQoL questionnaire for Italian and Japanese patients with Primary Biliary CirrhosisLorenzo Montali, Atsushi Tanaka, Paolo Riva, et al.Cancer Research|March 3, 2011
Ulcerative colitis-associated colorectal cancer arises in a field of short telomeres, senescence, and inflammationRosa Ana Risques, Lisa A Lai, Cigdem Himmetoglu, et al.Journal of Gastroenterology|August 10, 2020
The long-term outcomes of patients with immunoglobulin G4-related sclerosing cholangitis: the Mayo Clinic experienceAhmad Hassan Ali, Yan Bi, Jorge D Machicado, et al.The American Journal of Gastroenterology|July 23, 2026
Oral vancomycin is not associated with meaningful changes in liver-related endpoints among adults with primary sclerosing cholangitis: A randomized, placebo-controlled trialJohn E Eaton, Mitchell W Clayton, Denise M Harnois, et al.Journal of Hepatology|September 6, 2005
Effect of changes on body weight and lifestyle in nonalcoholic fatty liver diseaseAyako Suzuki, Keith Lindor, Jenny St Saver, et al.Archives of Surgery (Chicago, Ill. : 1960)|August 17, 2011
Liver transplantation for the treatment of liver metastases from neuroendocrine tumors: an analysis of the UNOS databaseRoberto Gedaly, Michael F Daily, Daniel Davenport, et al.Pageof 29